MedTech Resources

Device type · PZI

Prescription Use Blood Glucose Meter For Near-Patient Testing

FDA groups similar devices under a three-letter product code. This page gathers what FDA's public data says about PZI: how it is classified, what has been cleared or approved, and what has been reported and recalled.

Last checked: Nov 19, 2026Source: openFDAMethods & limitations

Product code

PZI

Clinical Chemistry

Device class

Class II

FDA decisions since 2015

13

510(k), De Novo and PMA

Adverse event reports

108

Received Nov 1, 2025 to Nov 19, 2026

How FDA classifies it

Device type
Prescription Use Blood Glucose Meter For Near-Patient Testing
Product code
PZI
Device class
Class II
Review panel
Clinical Chemistry
Regulation
21 CFR 862.1345

Latest FDA decisions

The 8 newest of 13 since 2015.

All decisions for PZI

Reports received

108

Received Nov 1, 2025 to Nov 19, 2026

Malfunction reports

100

93% of reports

Injury reports

4

3.7% of reports

Death reports

4

3.7% of reports

Adverse event reports received per month

By the date FDA received each report, stacked by event type. The newest month is incomplete.

Open in the MAUDE Monitor
  • Malfunction
  • Injury
  • Death
  • Other
View as table
MonthMalfunctionInjuryDeathOther
Dec 230000
Jan 240000
Feb 240000
Mar 240000
Apr 240000
May 240000
Jun 240000
Jul 240000
Aug 240000
Sep 242000
Oct 241000
Nov 242000
Dec 240000
Jan 252000
Feb 251000
Mar 251000
Apr 252000
May 257000
Jun 2515000
Jul 252000
Aug 250000
Sep 251000
Oct 250000
Nov 252000
Dec 252000
Jan 2611000
Feb 264000
Mar 267000
Apr 269100
May 264000
Jun 264010
Jul 262110
Aug 264120
Sep 2644100
Oct 267000
Nov 260000

Manufacturers named most often

Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.

Device problems as coded

Last 12 months. FDA's terms. A report can carry several.

  • Computer Software Problem67
  • Incorrect, Inadequate or Imprecise Result or Readings12
  • Output Problem8
  • Electrical /Electronic Property Problem4
  • High Test Results3
  • Low Test Results3
  • Non Reproducible Results3
  • Communication or Transmission Problem2
  • Connection Problem2
  • Incorrect Measurement2

Patient problems as coded

Last 12 months. FDA's terms. A report can carry several.

  • No Clinical Signs, Symptoms or Conditions100
  • Insufficient Information8
  • Hyperglycemia2
  • Hypoglycemia1

Recent recalls

From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.

  • Nova Biomedical Corporation

    Z-3128-2026 · Started Jul 29, 2026 · Posted by FDA Sep 11, 2026

    Reason given: A software synchronization/timing issue in the barcode scanning and patient data processing component that causes the device to intermittently retain a previously scanned barcode including patient identification (ID) barcodes and quality control (QC) solution ID barcodes when a new barcode is scanned, resulting in the...

    Cause as FDA categorized it: Software design

  • Nova Biomedical Corporation

    Z-3129-2026 · Started Jul 29, 2026 · Posted by FDA Sep 11, 2026

    Reason given: A software synchronization/timing issue in the barcode scanning and patient data processing component that causes the device to intermittently retain a previously scanned barcode including patient identification (ID) barcodes and quality control (QC) solution ID barcodes when a new barcode is scanned, resulting in the...

    Cause as FDA categorized it: Software design

  • Nova Biomedical Corporation

    Z-3130-2026 · Started Jul 29, 2026 · Posted by FDA Sep 11, 2026

    Reason given: A software synchronization/timing issue in the barcode scanning and patient data processing component that causes the device to intermittently retain a previously scanned barcode including patient identification (ID) barcodes and quality control (QC) solution ID barcodes when a new barcode is scanned, resulting in the...

    Cause as FDA categorized it: Software design

  • Nova Biomedical Corporation

    Z-3131-2026 · Started Jul 29, 2026 · Posted by FDA Sep 11, 2026

    Reason given: A software synchronization/timing issue in the barcode scanning and patient data processing component that causes the device to intermittently retain a previously scanned barcode including patient identification (ID) barcodes and quality control (QC) solution ID barcodes when a new barcode is scanned, resulting in the...

    Cause as FDA categorized it: Software design

  • Nova Biomedical Corporation

    Z-3132-2026 · Started Jul 29, 2026 · Posted by FDA Sep 11, 2026

    Reason given: A software synchronization/timing issue in the barcode scanning and patient data processing component that causes the device to intermittently retain a previously scanned barcode including patient identification (ID) barcodes and quality control (QC) solution ID barcodes when a new barcode is scanned, resulting in the...

    Cause as FDA categorized it: Software design

  • Nova Biomedical Corporation

    Z-0681-2025 · Started Nov 20, 2024 · Posted by FDA Dec 20, 2024

    Reason given: A software bug within the Gen 2 StatStrip Hospital Meter firmware leads to transmission of erroneous glucose patient test results to a healthcare institution's data management system (DMS) at healthcare sites using WiFi if a user navigates to the Review Results screen while the meter is in the process of transmitting...

    Cause as FDA categorized it: Software design

Back to all tools

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.